Study Evaluating TSE-424/Placebo/Raloxifene in Preventing Osteoporosis in Postmenopausal Women
Status:
Completed
Trial end date:
2004-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether TSE-424 (bazedoxifene acetate), an
investigational drug, is safe and effective in the prevention of osteoporosis in
postmenopausal women.